Psychedelic Stocks,Shroom News Maine Senate Approves Medical Psilocybin Proposal but House of Representatives Turns it Down By Dennis Mutua April 22, 2022 In the course of this week, the Maine Senate approved a medical psilocybin bill which is seeking to create a medical program across the state. However, the House of Representatives refused to pass the same bill. This bill was i...
Psychedelic Stocks,Shroom News MindMed Collaborators to Present Clinical Trial Results for LCD in Anxiety Disorder at PSYCH Symposium By Dennis Mutua April 19, 2022 Biopharmaceutical company developing psychedelics-inspired medicines and therapies to address addiction and brain health disorders MindMed Inc. (NASDAQ: MNMD) (NEO: MMED) announced that its collaborators at University Hospital Bas...
Psychedelic Stocks,Shroom News Filament Health Granted Patent for Extraction and Standardization of Natural Psilocybin By Dennis Mutua April 14, 2022 Clinical stage natural psychedelic drug development company supporting treatment of mental health conditions Filament Health Corp. (NEO: FH) (OTCQB: FLHLF) has received a patent allowing it to extract and standardize natural psilo...
Psychedelic Stocks,Shroom News Cybin Applies for International PCT Patent for Inhalation Delivery of Multiple Psychedelics Molecules By Dennis Mutua April 11, 2022 Biopharmaceutical company focusing on advancing psychedelic pharmaceutical treatments for various psychiatric and neurological conditions Cybin Inc. (NYSE American: CYBN) (NEO: CYBN) announced that the World Intellectual Property ...
Psychedelic Stocks,Shroom News Silo Pharma Inks Agreement with Frontage Laboratories for Pharmacokinetic Study By Dennis Mutua April 01, 2022 Development stage biopharmaceutical company focusing on merging traditional therapies with psychedelic research Silo Pharma Inc. (OTCMKTS: SILO) has signed an agreement deal with Frontage Laboratories for Pharmacokinetic Study. ...
Featured,Shroom News Georgia Legislators Pass Bill to Form Psychedelic Study Committee By Dennis Mutua March 30, 2022 Lawmakers from Georgia have passed a bill advocating for the creation of a psychedelic study committee which will be dedicated in investigating the therapeutic potential of psychedelics like psilocybin, MDMA, DMT among others. The...
Psychedelic Stocks,Shroom News NeonMind Submits Patent Application for Psilocybin Induced Weight Loss By Dennis Mutua March 24, 2022 Integrated psychedelic drug development and wellness company focusing on therapeutic uses of psychedelics to address mental illnesses NeonMind Biosciences Inc. (CSE: NEON) (OTCQB: NMDBF) has submitted a new patent application for ...
Psychedelic Stocks,Shroom News Nova Mentis Closes a Non-Brokered Private Placement By Dennis Mutua March 16, 2022 Biotechnology company focusing on developing diagnostics and psilocybin based therapeutics and complementary diagnostics for neuroinflammatory disorders Nova Mentis Life Sciences Corp. (CSE: NOVA) (OTCQB: NMLSF) announced having c...
